Liu Li, Guo Shengrong, Chang Jiang, Ning Congqin, Dong Changming, Yan Deyue
School of Pharmacy, Shanghai Jiaotong University, Shanghai 200240, People's Republic of China.
J Biomed Mater Res B Appl Biomater. 2008 Oct;87(1):244-50. doi: 10.1002/jbm.b.31103.
The polycaprolactone (PCL) membranes were successfully modified by deposition of chitosan/heparin multilayer via a simple electrostatic self-assembly method. To immobilize chitosan, a novel ternary polysaccharide derivate, chitosan-g-PCL-b-poly-(ethylene glycol) (PEG) was used coating on PCL film first, which resulted in the presence of positive charges onto PCL surface as the basis for following electrostatic self-assembly. The process of modification was monitored by X-ray photoelectron spectroscopy, static contact angle measurement, and atomic force microscopy. The chitosan-g-PCL-b-PEG/heparin complex immobilized on PCL surface presented it with increasing hydrophilicity and microphase separation structure. Then in vitro hemocompability experiments indicated that this multilayer deposition on PCL resisted the platelets adhesion and prolonged the plasma recalcification time effectively, relative to the untreated PCL. Such chitosan-g-PCL-b-PEG/heparin-modified PCL may have good potential for use in vascular tissue engineering.
通过简单的静电自组装方法,成功地在聚己内酯(PCL)膜上沉积壳聚糖/肝素多层膜对其进行了改性。为了固定壳聚糖,首先使用一种新型三元多糖衍生物壳聚糖-g-PCL-b-聚乙二醇(PEG)涂覆在PCL膜上,这使得PCL表面带有正电荷,作为后续静电自组装的基础。通过X射线光电子能谱、静态接触角测量和原子力显微镜对改性过程进行了监测。固定在PCL表面的壳聚糖-g-PCL-b-PEG/肝素复合物使其具有增加的亲水性和微相分离结构。然后体外血液相容性实验表明,相对于未处理的PCL,PCL上的这种多层沉积有效地抵抗了血小板粘附并延长了血浆再钙化时间。这种壳聚糖-g-PCL-b-PEG/肝素改性的PCL在血管组织工程中可能具有良好的应用潜力。